DUALITYBIO-B 09606Hong Kong Stock Exchange

182.7002.14%( -4.000 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
DUALITYBIO-B (09606) Company Profile - Company Info, Industry & Management - cibo

Company Information

Company Name
Duality Biotherapeutics, Inc.
Market
HKEX Main Board
Listing Date
2025-04-15
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
KYG2929M1087
Southbound Connect
Shanghai · Shenzhen

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)2.17B39/112
Net Profit (Last FY)-3.04B122/125
ROE (Last FY)-106.93%110/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
朱忠远 Executive Director
张韶壬 Executive Director
花海清 Executive Director
蔡志洋 Non-Executive Director
余涛 Non-Executive Director
谢东 Independent Non-Executive Director
高凤勇 Independent Non-Executive Director
揣姝茵 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-03-23.

About this page

This page shows DUALITYBIO-B (09606) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.